Search results
Results from the WOW.Com Content Network
Luspatercept, sold under the brand name Reblozyl, is a medication used for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. [ 5 ] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication .
Ferric maltol was approved for medical use in the European Union in February 2016. [ 5 ] Ferric maltol was approved for medical use in the United States in July 2019, [ 4 ] [ 10 ] based on evidence from three clinical trials (trial 1/NCT01252221, trial 2/NCT01340872, [ 11 ] and trial 3/NCT02968368 [ 12 ] ). [ 3 ]
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
The FDA approval for sleep apnea is based on two company-sponsored trials encompassing about 470 participants, one in which patients were being treated with continuous positive air pressure, ...
For premium support please call: 800-290-4726 more ways to reach us
Iqirvo's approval was based on data from a 161-patient late-stage trial, in which it reduced levels of an enzyme called alkaline phosphatase that can lead to liver damage.
Luspatercept was shown to decrease the need for transfusions and this effect lasted for a median of 30.6 weeks. [ 51 ] [ 36 ] [ 52 ] HLA -matched allogeneic stem cell transplantation , particularly in younger (i.e. less than 40 years of age) and more severely affected patients, offers the potential for curative therapy.
Two West Point Cadets made history earlier this year when they became the first women to graduate from Army Ranger School. Enlistment numbers for minorities tell a similar story. In 2012, approximately 30 percent of active-duty soldiers didn't identify as white.